Management


Johan Björkegren

Johan Björkegren M.D, Ph.D, M.B.A

Dr. Björkegren is the founder of CGN and Associate Professor in Molecular Medicine at the Karolinska Institutet where he is the head of the Cardiovascuar Genomics group (cardiovasculargenomics.se) at the Division of Vascular Biology and Department of Medical Biochemistry and Biophysics. He is also Professor of genetics and genomics at the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, NY US. Since 2010, Johan Björkegren is professor in molecular pathology at the Department of Medical Pathology and Forensic Medicine, University of Tartu, Estonia. Since 2013, Björkegren is chair of the board in CGN and main shareholder. 


Arno Ruusalepp

Arno Ruusalepp, M.D, Ph.D.

Is staff surgeon at Tartu University Hospital performing most of adult cardiac surgery at our department. He is responsible for building new biobanks in CGN. Areas of my surgical expertise involve CABG, OPCAB, MIDCAB, aortic and mitral valve repair, aortic valve and aortic surgery via ministernotomy, aortic surgery and AF surgery. My research interests involve myocardial protection, mitochondrial function in heart diseases and genetics of coronary artery disease. Positions and Honors (chronological order). Dr. Ruusalepp President of "Estonian Society of Cardiac Surgery" since 2007, Member of European Association of Cardio-Thoracic Surgery since 2002, Member of Estonian Surgeons Society since 1997. SInce 2011, Dr. Arno Ruusalepp is member of the Board in CGN.


eric.schadt@mssm.edu

Eric E Schadt

Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. His research has provided novel insights into what is needed to master diverse, large-scale data collected on normal and disease populations in order to elucidate the complexity of disease and make more informed decisions in the drug discovery arena.  He has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes and obesity, which have been widely published in leading scientific journals.

Dr. Schadt is currently chair of the Department of Genetics and Genomic Sciences and Institute of Genomics and Multiscale Biology at the Icahn School of Medicine at the Mount Sinai, NY, US. 

Since 2013, Dr Schadt is member of the board of directors in CGN.